Lamivudine Plus Adefovir Combination Therapy Versus Entecavir Monotherapy for Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis

Virology Journal - United Kingdom
doi 10.1186/1743-422x-8-393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Lamivudine Plus Adefovir Therapy in Chronic Hepatitis B Iranian Patients, Resistant to Lamivudine Treatment Alone, on Disease Inhibition: A Pilot Study

Open Journal of Gastroenterology
2012English

Erratum To: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B

Digestive Diseases and Sciences
PhysiologyGastroenterology
2011English

Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil

Gut
Gastroenterology
2006English

Renal Dysfunction and Hypophosphatemia During Long-Term Lamivudine Plus Adefovir Dipivoxil Therapy in Patients With Chronic Hepatitis B

Journal of Gastroenterology
Gastroenterology
2013English

The Efficacy of Adefovir Dipivoxil Monotherapy and the Incidence of Genotypic Resistance to Adefovir Dipivoxil in Patients With Lamivudine-Resistant Chronic Hepatitis B Infection

The Korean Journal of Hepatology
2008English

Comparison of the Clinical Outcomes Between Antiviral-Naïve Patients Treated With Entecavir and Lamivudine-Resistant Patients Receiving Adefovir Add-On Lamivudine Combination Treatment

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2016English

Evaluation of Long-Term Entecavir Treatment in Stable Chronic Hepatitis B Patients Switched From Lamivudine Therapy

Hepatology International
Hepatology
2010English

Immunomodulatory Effects of Combination Therapy With Bushen Formula Plus Entecavir for Chronic Hepatitis B Patients

Journal of Immunology Research
MedicineAllergyImmunology
2019English

The Effect of Prophylactic Lamivudine Plus Adefovir Therapy Compared With Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients With High Baseline HBV DNA During Chemotherapy

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy